Lewis H. Bender
Known title: President and CEOCIK: 0001238705
Associated companies
Transaction History
| INTS | ▲ Buy | Grant | 37,749 | $231K | 3/26/2026 | View on chart |
| INTS | ▲ Buy | Grant | 37,749 | $231K | 3/26/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
INTS Joins 12 Health Care Stocks Moving After-Market
Intensity Therapeutics was one of 12 healthcare stocks that moved in Wednesday's after‑market session. The move shows that the stock attracted extra trading after hours, which can affect its price in the next session. The stock is trading near its 13‑touch support level of $4.00 and has a moderate RSI of 44.4. The high‑beta signal suggests it may be more volatile than the broader market.
INTS Joins 12 Health Care Stocks Moving After-Market. Intensity Therapeutics was one of 12 healthcare stocks that moved in Wednesday's after‑market session. The move shows that the stock attracted extra trading after hours, which can affect its price in the next session. The stock is trading near its 13‑touch support level of $4.00 and has a moderate RSI of 44.4. The high‑beta signal suggests it may be more volatile than the broader market.